Literature DB >> 18849317

Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.

Irem Hicran Ozbudak1, Gulay Ozbilim, Ilknur Kucukosmanoglu, Levent Dertsiz, Abid Demircan.   

Abstract

The prognostic significance of microvascular density (MVD) and vascular endothelial growth factor (VEGF) expression were investigated in 15 patients with adenocarcinoma (AC) and 15 patients with squamous cell carcinoma (SCC). Immunohistochemically, VEGF and factor VIII were applied. The average microvessel counts were given as MVD, and VEGF expression was given as VEGF percentage area and VEGF staining degree. Higher values of MVD were obtained in patients with AC (11.47 +/- 3.48) when compared with patients with SCC (7.47 +/- 2.50; P = .001) and also in patients at early stages of disease (10.77 +/- 3.24) when compared with patients at advanced stages (8.47 +/- 3.64; P = .050). A significant correlation was shown between MVD and VEGF percentage area (P = .006) and between VEGF percentage area and VEGF staining degree (P = .000). No significant difference was found in VEGF percentage area between patients with SCC and AC and between patients at early and advanced stages. In conclusion, VEGF or MVD should not be regarded as a solitary prognostic factor but should be supported by other prognostic factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849317     DOI: 10.1177/1066896908323506

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  1 in total

1.  Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.

Authors:  Dylan M Glubb; Elisa Cerri; Alexandra Giese; Wei Zhang; Osman Mirza; Emma E Thompson; Peixian Chen; Soma Das; Jacek Jassem; Witold Rzyman; Mark W Lingen; Ravi Salgia; Fred R Hirsch; Rafal Dziadziuszko; Kurt Ballmer-Hofer; Federico Innocenti
Journal:  Clin Cancer Res       Date:  2011-06-28       Impact factor: 12.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.